KAROS PHARMACEUTICALS INC has a total of 22 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Argentina. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are BIAL PORTELA & CA SA, BIOPROJET SOC CIV and AURIGENE DISCOVERY TECH LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Argentina | 1 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | Chile | 1 | |
#8 | China | 1 | |
#9 | Ecuador | 1 | |
#10 | Hong Kong | 1 | |
#11 | Republic of Korea | 1 | |
#12 | Mexico | 1 | |
#13 | Peru | 1 | |
#14 | Philippines | 1 | |
#15 | Singapore | 1 | |
#16 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Goldberg Daniel R | 18 |
#2 | Sjogren Eric Brian | 15 |
#3 | Brameld Kenneth | 14 |
#4 | Scribner Andrew | 12 |
#5 | De Lombaert Stéphane | 10 |
#6 | De Lombaert Stephane | 5 |
#7 | Andrew Scribner | 4 |
#8 | Eric Brian Sjogren | 4 |
#9 | Kenneth Brameld | 4 |
#10 | Daniel R Goldberg | 4 |
Publication | Filing date | Title |
---|---|---|
US2016257633A1 | Processes for preparing (R)-1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanone | |
WO2016109501A1 | Amide compounds as tryptophan hydroxylase inhibitors | |
WO2015089137A1 | Acylguanidines as tryptophan hydroxylase inhibitors | |
AR097571A1 | SIPROCYCLIC COMPOUNDS AS INHIBITORS OF HYDROXYLASE TRIPTOPHAN |